Journal
BIOCHEMICAL PHARMACOLOGY
Volume 165, Issue -, Pages 112-125Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2019.04.009
Keywords
Corticosteroids; Rheumatoid arthritis; DMARDs; Side effects; Vasculitis; Lupus erythematosus
Categories
Funding
- FWO (Fonds Wetenschappelijk onderzoek) [G012618N]
Ask authors/readers for more resources
Glucocorticoids (GCs) constitute a first line treatment for many autoimmune and inflammatory diseases. Due to their potent anti-inflammatory and immunosuppressive actions, GCs are added frequently to disease modifying antirheumatic drugs (DMARDs) in various arthritic diseases, such as rheumatoid arthritis. However, their prolonged administration or administration at high doses is associated with adverse effects that may be (quality of) life-threatening, including osteoporosis, metabolic, gastrointestinal and cardiovascular side effects. In this review, we summarize the clinical and pharmacological effects of GCs in different arthritic diseases, while documenting the current research efforts towards the identification of novel and more efficient GCs with reduced side effects.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available